Humana (NYSE:HUM) traded ~7% higher in the premarket on Wednesday after the managed care firm, with its Q2 2025 results, ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

Key Takeaways Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than ...

Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.

Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell ...

Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted ...

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

The company updated full-year revenue expectations to at least $128 billion, a $2 billion increase over its prior projection.

Humana Wednesday reported $545 million in second quarter profits as the health insurer’s medical cost trends fell in line ...

Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher ...